Celgene and Juno Announce Ten-Year Collaboration to Advance Potentially Groundbreaking Immunotherapies for Patients with Cancer and Autoimmune Diseases
June 29, 2015 at 16:07 PM EDT
Celgene Corporation (Nasdaq: CELG) and Juno Therapeutics, Inc. (Nasdaq: JUNO) announced today a global collaboration for the development ...